Teriflunomide for multiple sclerosis in real-world setting.

M L ElkjaerT MolnarZsolt Illes

Published in: Acta neurologica Scandinavica (2017)

Efficacy and safety of teriflunomide in real-life setting support data obtained by the pivotal trials. Laboratory abnormalities are rare among the large number of samples, but patients may commonly have a single mild, abnormal value if frequently tested.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
electronic health record
white matter
deep learning
artificial intelligence